Free Trial
NASDAQ:ABVC

ABVC BioPharma (ABVC) Stock Price, News & Analysis

ABVC BioPharma logo
$5.25 +1.26 (+31.58%)
As of 01:46 PM Eastern

About ABVC BioPharma Stock (NASDAQ:ABVC)

Key Stats

Today's Range
$4.07
$5.48
50-Day Range
$1.03
$3.99
52-Week Range
$0.40
$5.47
Volume
1.65 million shs
Average Volume
337,901 shs
Market Capitalization
$89.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ABVC BioPharma Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
14th Percentile Overall Score

ABVC MarketRank™: 

ABVC BioPharma scored higher than 14% of companies evaluated by MarketBeat, and ranked 872nd out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for ABVC BioPharma.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of ABVC BioPharma is -37.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of ABVC BioPharma is -37.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    ABVC BioPharma has a P/B Ratio of 84.57. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about ABVC BioPharma's valuation and earnings.
  • Percentage of Shares Shorted

    3.49% of the float of ABVC BioPharma has been sold short.
  • Short Interest Ratio / Days to Cover

    ABVC BioPharma has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in ABVC BioPharma has recently increased by 12.54%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    ABVC BioPharma does not currently pay a dividend.

  • Dividend Growth

    ABVC BioPharma does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.49% of the float of ABVC BioPharma has been sold short.
  • Short Interest Ratio / Days to Cover

    ABVC BioPharma has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in ABVC BioPharma has recently increased by 12.54%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    ABVC BioPharma has a news sentiment score of 1.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for ABVC BioPharma this week, compared to 0 articles on an average week.
  • Search Interest

    3 people have searched for ABVC on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, ABVC BioPharma insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    17.10% of the stock of ABVC BioPharma is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 11.38% of the stock of ABVC BioPharma is held by institutions.

  • Read more about ABVC BioPharma's insider trading history.
Receive ABVC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ABVC BioPharma and its competitors with MarketBeat's FREE daily newsletter.

ABVC Stock News Headlines

ABVC BioPharma Inc Price vs Fair Value - Morningstar
"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
See More Headlines

ABVC Stock Analysis - Frequently Asked Questions

ABVC BioPharma's stock was trading at $0.59 at the start of the year. Since then, ABVC shares have increased by 760.0% and is now trading at $5.0740.

ABVC BioPharma, Inc. (NASDAQ:ABVC) issued its quarterly earnings data on Wednesday, April, 30th. The company reported ($0.06) earnings per share (EPS) for the quarter. ABVC BioPharma had a negative net margin of 963.46% and a negative trailing twelve-month return on equity of 29.62%.

ABVC BioPharma shares reverse split on Tuesday, July 25th 2023.The 1-10 reverse split was announced on Tuesday, July 25th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, July 25th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

ABVC BioPharma (ABVC) raised $7 million in an initial public offering (IPO) on Tuesday, August 3rd 2021. The company issued 1,100,000 shares at $6.25 per share.

Shares of ABVC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ABVC BioPharma investors own include Meta Platforms (META), NIO (NIO), ObsEva (OBSV), Tesla (TSLA), Alibaba Group (BABA), ChargePoint (CHPT) and Walt Disney (DIS).

Company Calendar

Last Earnings
4/30/2025
Today
7/08/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ABVC
Fax
N/A
Employees
30
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$4.90 million
Net Margins
-963.46%
Pretax Margin
-666.53%

Debt

Sales & Book Value

Annual Sales
$510 thousand
Price / Cash Flow
N/A
Book Value
$0.06 per share
Price / Book
66.50

Miscellaneous

Free Float
14,078,000
Market Cap
$67.75 million
Optionable
Not Optionable
Beta
0.37
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:ABVC) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners